Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1980-4-17
pubmed:abstractText
Clofibrinic acid in saliva and plasma and its plasma protein binding were determined in 18 patients with renal impairment after a single 2-gm dose of clofibrate. A weak but significant correlation (r2 = 0.378; p less than 0.02) between free plasma and saliva levels of clofibrinic acid was found. The free fraction of clofibrinic acid in plasma is higher (p less than 0.02) in long-term hemodialysis patients (0.0915 +/- 0.0141) than in nondialysis patients (0.0715 +/- 0.0143). During dialysis, 2 hemodialysis patients had a free fraction more than twice as high (mean, 0.2083) as that in the other hemodialysis patients who were studied on interdialysis days. These observations suggest that saliva pH determinations are essential for optimal interpretation of saliva to plasma level ratios of weakly acidic drugs and that, during hemodialysis, patients may temporarily be exposed to increased risks of drug toxicity due to rises in free concentrations of drugs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0009-9236
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients.
pubmed:publicationType
Journal Article